This article has been updated from an earlier version that misstated the percentage of revenues from life science mass spectrometry systems.
NEW YORK, May 5 (GenomeWeb News) - Bruker BioSciences yesterday reported increased revenues and earnings for the first quarter of 2004.
Revenues for the quarter were $68.2 million, up from $63.1 million during the first quarter of 2003. Approximately 40 percenrt of these revenues resulted from life science mass spectrometry systems.
R&D expenses increased to $10.4 million, up from $8.8 million during the year-ago period.
Bruker's net earnings totaled $1 million, or $.01 per share, up from a net loss of $1.6 million, or $.02 per share, during the same quarter last year.
As of March 31, Bruker had $76.7 million in cash and short-term investments.